Specialty Pharmacy

Cheryl Allen, vice president of Industry Relations at Diplomat Specialty Pharmacy, discusses the elements of an effective, high touch patient care program.

Patients with HIV can now expect to live into old age, and therefore need links to the community health network.

Isentress HD is a once daily treatment for HIV-1 that helps patients achieve viral suppression.

GLUT1 inhibitors could be a potential therapeutic target for the squamous subtype of cancer.

Society for Integrative Oncology releases updated clinical guidelines on integrative breast cancer treatments.

Tocilizumab (Actemra) is the first drug approved to treat giant cell arteritis.

Leader and follower cells depend on each other for survival and invasion.

Top news of the day from across the health care landscape.

Sheila Arquette, RPh, discusses optimal patient support programs in specialty pharmacy.

A how-to guide for pharmacy school students interested in pursuing a career in specialty pharmacy.

A cancer diagnosis can cause up to a 3.5% reduction in earnings for men and up to 6% for women.

Ceritinib (Zykadia) approved to treat anaplastic lymphoma kinase-positive metastatic non-small cell lung cancer.

Carboplatin plus birinapant effective against high-grade serious ovarian cancer.

Fampyra significantly improved walking and enhanced quality of life in patients with multiple sclerosis.

Top news of the day from across the health care landscape.

Patient genotypes of in both hepatitis C and advanced cirrhosis may help predict outcomes with direct-acting antiviral drugs.

Imaging technology highlights cancerous features of a breast tumor.

Top articles of the week from The American Journal of Pharmacy Benefits.

Study will assess improvements in mobility and changes in disability in patients with MS.

Early microbial changes may identify patients most likely to achieve and maintain treatment response.

Novel strategy prolongs immune system defense against HIV.

Novel combination may improve treatment options for castration resistant prostate cancer.

New diagnoses of squamous cell carcinoma increased 263% and basal cell carcinoma increased 145%.

Scientists override tumor growth effects of PTEN deletion.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Top articles of the week from Specialty Pharmacy Times.

Epoetin alfa biosimilar has indications in cancer, HIV, and chronic kidney disease, among other conditions.

This is the first recommendation for a proposed erythropoiesis-stimulating agent biosimilar.